Every Healthcare Consulting Firm Now Claims the Same Differentiator

Key Insights

• Practitioner depth is now the default claim, not a differentiator. Nearly every firm we heard from led with clinicians, former operators, and industry veterans on staff – so none of them stood out for it.
• Firms write like generalists and talk like specialists. Submissions claimed the full sector, then the conversations kept returning to the few problems each firm actually wins.
• The firms that stood apart did it by drawing a boundary. They said no to adjacent work and turned the objection buyers raise most into their strongest proof point.

---

Ask a healthcare consulting firm what makes it different, and you'll almost always hear two answers. We hire practitioners. We implement, not just advise.

Ask the next firm, and the one after that, and you'll hear the same two answers again.

That pattern ran through the practice leader conversations, firm submissions, and independent research behind Management Consulted's 2027 Top Healthcare Consulting Firms ranking. Firms that compete for different buyers, with different economics, described themselves in nearly identical terms.

The ranking defines healthcare as the full sector: providers, payers, government health, pharma and biotech, medtech, diagnostics, and digital health. In practice, that's two markets – care delivery and life sciences – that share a label and very little else. The convergence below held across both. Where a finding bites harder on one side, we say so.

The industry has converged on a differentiator that buyers can no longer use to choose between firms.

Practitioner Depth Stopped Being an Edge Once Everyone Hired for It

A decade ago, "our team includes former clinicians and industry executives" meant something. Many of the largest strategy firms staffed healthcare work with strong generalists, and a firm that could put a former hospital operator or an ex-pharma launch lead in the room had a real advantage.

Now every serious competitor makes the claim, often with a number attached. One firm told us the majority of its team had worked in the industry as practitioners. Another put the share of its team with operational, service management, or clinical backgrounds at 70 to 80%. A third said the vast majority of its people hold life sciences degrees and can "go toe-to-toe" with any client.

All true. None of it separates one firm from the next. The claim that once set a firm apart now just qualifies it for the shortlist.

The second claim has followed the same path. "We don't just give the reports and walk away," one leader said. Another described taking work from strategy "all the way through to implementation." A third said its leaders are "actually part of the delivery."

A third claim is catching up fast: we leave you more capable. Submissions promised improvements "sustained long after we leave" or teams that end up "more capable, not more dependent."

In care delivery, where the work is revenue cycle, capacity, and workforce, implementation is the product – which makes the claim true of almost everyone competing for that work. In life sciences, "we execute" usually means launch support and commercial operations, and the buyer hears it from every firm on the list.

When every firm makes the same claim, the claim stops carrying information. The buyer has to decide on something else, and that something else is rarely what the firm put in its pitch.

Firms Write Like Generalists and Talk Like Specialists

The sharpest finding in this research came from comparing what firms wrote with what they said.

On paper, firms described themselves as full-spectrum. Capability lists covered providers, payers, pharma, medtech, digital health, and government, often in the same sentence. The written answer was built for a hypothetical buyer who might need anything.

The calls sounded different. One firm checked nearly every client segment on its submission. On the call, asked whether its mix leaned toward providers, the team said it was "really broad, actually." Later in the same conversation, a colleague introduced the firm's strongest point with: "I'm talking very much in the kind of provider world."

That point was the most distinctive thing we heard from the firm, and it wasn't in the submission. Its consultants work alongside frontline clinicians who have seen plenty of consultants and whose "initial reaction is always negative." The team works with those clinicians rather than telling them what to do. Clients describe it, the leader said, as "standing out because we fit in."

That's positioning. It's specific, a buyer can test it, and a competitor can't copy it by swapping a logo.

The positioning most firms need is already in their partners' mouths – it just never makes it onto the page.

Why the gap exists is not a mystery. A submission gets reviewed by marketing, legal, and every practice that doesn't want to be left out. A call is one leader thinking out loud about work they've done. The first process sands down every edge. The second one can't.

The Firms That Stood Out Built Their Pitch Around a Boundary

A few firms rejected the breadth claim entirely. Two stood out.

The first won't follow demand outside its lane. "People say, why don't you expand to healthcare, like, payers, providers, hospitals?" its leader said. "That's not our space." The firm's leadership is "so laser-focused on not expanding beyond the spaces in which we are experts" – a discipline the leader admitted is "scary to do when you see the economy go up and down."

The second wrote its boundary into the submission: its domain expertise "isn't one practice among many, it's the entire firm." Then it turned that narrowness into the sales argument.

A prospective client's executives worried the firm did so much work in their space that sharing sensitive information would be risky. The firm agreed. Every engagement it runs, the leader told them, is for "either your customers or your competitors." Then it made that the pitch: every person on the team, "all the way down to the analysts," would already know the client's entire portfolio.

The objection became the proof. That's not a slogan. It's a claim a buyer can test in the first meeting.

The same leader drew the contrast with generalist firms directly. A consultant there can work for an oil company, then an aircraft maker, then a drugmaker. "This is not the way that you build expertise in one space."

Both firms described their boundary as a choice with a cost. "Ultimately, strategy is about making a bet," one said. Most firms never place it.

This bites hardest in life sciences, where segments like diagnostics, clinical development, and pricing under Medicare negotiation each run on their own science, regulators, and buyers. Care delivery segments overlap more, but the same logic holds: a firm that names the exact health system problem it solves is easier to hire than one that claims to solve all of them.

A Boundary You Choose Is Not the Same as a Market You're Missing

A reader moving between this article and the ranking could reasonably ask a question. If focus is the strongest position in the market, why does the ranking's top 10 lean toward firms credible on both sides of the care delivery and life sciences divide?

Because they measure different things.

A full-sector ranking asks whether a firm can serve a buyer across providers, payers, pharma, medtech, and diagnostics. Reach across that divide is part of what it rewards. A segment asks who leads a specific kind of work. A chosen boundary is the strongest position available inside a segment. That's why the ranking includes a segment market map naming a leader for each one, including firms that sit outside the top 10 on scope rather than quality.

Both are valid positions. They compete in different sets.

The weak position is the one in between. A firm that claims the whole sector in writing but is absent from half of it in practice gets evaluated against the broadest firms – and loses to them. It also never gets credit as a segment leader, because it never claimed a segment.

Most firms we heard from sit in that middle. They claim breadth on paper and win on focus in conversation. That's the uncomfortable finding for firm leaders reading this: the convergence problem isn't only a market condition. It's a choice each firm keeps making.

What This Means for Firm Leaders

Retire practitioner depth as your headline. Keep it as proof. Lead with the problem you solve better than the next firm, and let the résumés support that claim.

Write the submission the way your partners talk. Record your best partners describing the work they win most often. The specific problems, language, and outcomes in those conversations are your positioning. The capability list is not.

Decide which competitive set you're in. If you compete across both care delivery and life sciences, prove it with named work on each side. If you've chosen one segment, say so plainly and compete to lead it – that's where buyers and rankings will evaluate you.

Name what you don't do. A boundary makes every claim inside it more credible. Buyers trust a firm that turns work away more than one that takes everything.

Turn your hardest objection into proof. Whatever buyers push back on most – conflicts, size, cost – ask whether it's actually evidence for your position.

Run the logo test. Swap your logo onto a competitor's positioning page. If nothing breaks, you don't have positioning yet.

The Bottom Line

Healthcare consulting firms have spent years building the same strengths, and they've succeeded. Practitioner depth and execution capability are now everywhere.

That success created the problem. A buyer can't choose between firms using claims every firm makes.

The firms that stand out in 2027 aren't the broadest. They're the ones that can say exactly what they do, where they stop, and why that boundary makes them better. Most firms already have that answer. It's sitting in their partners' conversations, waiting to be written down.

FAQ: Healthcare Consulting Firm Positioning